Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
- 1Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China
- 2Department of Medical Oncology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
- 3Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
- 4Department of Gastroenterology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China
A Corrigendum on
Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
by Wu W, Liu S, Tian L, Li C, Jiang Y, Wang J, Lv Y, Guo J, Xing D, Zhai Y, Sun H, Li Y, Zhang L, He X, Luo K, Zhan H and Zhao Z (2023). Front. Genet. 13:1092678. doi: 10.3389/fgene.2022.1092678
In the published article, there was an error in Affiliation(s) “3”. Instead of “Department of Gastroenterology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Jinan, China”, it should be “Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.”
Also, for author “Hongjie Zhan”, the city in the affiliation is corrected from “Jinan” to “Tinajin” and its was renumbered to 4: “Department of Gastroenterology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: DLBCL, microtube-associated genes, prognostic model, targeting therapy, TMEM63A
Citation: Wu W, Liu S, Tian L, Li C, Jiang Y, Wang J, Lv Y, Guo J, Xing D, Zhai Y, Sun H, Li Y, Zhang L, He X, Luo K, Zhan H and Zhao Z (2023) Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction. Front. Genet. 14:1180076. doi: 10.3389/fgene.2023.1180076
Received: 05 March 2023; Accepted: 18 April 2023;
Published: 08 June 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Wu, Liu, Tian, Li, Jiang, Wang, Lv, Guo, Xing, Zhai, Sun, Li, Zhang, He, Luo, Zhan and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hongjie Zhan, hongjiezhan@163.com Zhigang Zhao, zzhao01@tmu.edu.cn
†These authors share first authorship